EGFR and cancer: The unfavorable prognosis of LS1 may be associated with pathways like ERBB signaling, fatty acid metabolism, unsaturated fatty acid biosynthesis, the pentose phosphate pathway, fructose and mannose metabolism, and tight junctions, all of which likely play roles in promoting cancer cell proliferation, survival, migration, invasion, and metastasis.